Clinical Trial Update: EASYTRAK 3 Downsize Lead [Phase 2, Phase 3]

View source ↗

Summary

The EASYTRAK 3 Downsize Lead trial in heart failure (Phase 2/3) has completed. Sponsor: Boston Scientific Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Heart Failure | Phase 2, Phase 3 | Status: COMPLETED